Home > Anthera Pharmaceuticals Salary

Anthera Pharmaceuticals Salary

  • 100
  • 33
  • 27
Anthera Pharmaceuticals average salary is $119,250, median salary is $119,250 with a salary range from $116,500 to $122,000.
Anthera Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Anthera Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
116,500
Average
119,250
Median
119,250
High
122,000
Total 2 Anthera Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Information System Manager 122,000-122,000 Houston, TX, 77001 2015 Anthera Pharmaceuticals Information System Manager Salaries (2)
Anthera Pharmaceuticals Houston, TX Salaries
Information System Manager 116,500-116,500 Houston, TX, 77001 2012 Anthera Pharmaceuticals Information System Manager Salaries (2)
Anthera Pharmaceuticals Houston, TX Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Anthera Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Anthera Pharmaceuticals Jobs
See more Anthera Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Anthera Pharmaceutical... Information
  • Anthera Pharmaceuticals, Inc
  • Industry: Major Drugs
  • City: Hayward, CA
  • Anthera Pharmaceuticals is a start-up pharmaceutical company focused on the in-licensing of promising clinical candidates for the treatment of serious respiratory and inflammatory diseases. Anthera has identified four clinical stage products which have the potential address a variety of these target diseases including: Acute Lung Injury, Cystic Fibrosis, COPD, Asthma, and idiopathic pulmonary fibrosis.